Panitumumab Interactions
There are 32 drugs known to interact with panitumumab, along with 5 disease interactions. Of the total drug interactions, 11 are major, and 21 are moderate.
- View all 32 medications that may interact with panitumumab
- View panitumumab disease interactions (5)
Most frequently checked interactions
View interaction reports for panitumumab and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Abraxane (paclitaxel protein-bound)
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Activated Charcoal (charcoal)
- Activated Charcoal (charcoal)
- Adriamycin (doxorubicin)
- Adriamycin (doxorubicin)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- AquADEKs (multivitamin with minerals)
- AquADEKs (multivitamin with minerals)
- Aspirin Low Strength (aspirin)
- Aspirin Low Strength (aspirin)
- Avapro (irbesartan)
- Avapro (irbesartan)
- Avastin (bevacizumab)
- Avastin (bevacizumab)
- Fentanyl Transdermal System (fentanyl)
- Fentanyl Transdermal System (fentanyl)
- Paracetamol (acetaminophen)
- Paracetamol (acetaminophen)
- Retinol (vitamin a topical)
- Retinol (vitamin a topical)
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
Panitumumab disease interactions
There are 5 disease interactions with panitumumab which include:
- CV/electrolyte imbalance
- dermatologic toxicities
- ocular disorders
- pulmonary toxicity
- liver/renal impairment
Report options
More about panitumumab
- panitumumab consumer information
- Compare alternatives
- Reviews (7)
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Betaseron
Betaseron is used to treat relapsing multiple sclerosis (MS). Learn about side effects ...
Leucovorin
Leucovorin is used for anemia, megaloblastic, colorectal cancer, folic acid antagonist overdose ...
Oxaliplatin
Oxaliplatin (Eloxatin) is a cytotoxic chemotherapy drug used to treat stage III colon cancer and ...
Nivolumab
Nivolumab is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Bevacizumab
Bevacizumab injection is a targeted cancer drug used to treat types of non-small cell lung cancer ...
Fluorouracil
Fluorouracil is used for anal cancer, breast cancer, breast cancer, palliative, cancer, cervical ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.